EichorEICHOR
Location: Amsterdam Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Amsterdam

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Transcranial Magnetic Stimulation to Slow Down Cognitive Decline in Alzheimer's Disease
NA · Amsterdam UMC · Willem de Haan · NCT07036328
Assessment of the Alignment of the Atlas and Surrounding Tissues in Chronic Whiplash Associated Disorder
Phase N/A · Amsterdam UMC · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06413667
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Amsterdam UMC, locatie VUmc · Eli Lilly and Company · NCT07218380
Single-dose Preoperative Partial Breast Irradiation in Low-risk Breast Cancer Patients
NA · Amsterdam UMC · Amsterdam UMC, location VUmc · NCT05350722
A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients Wit
Phase 1 · Amsterdam UMC Stichting · eleva GmbH · NCT07483827
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Local Institution - 0033 · Bristol-Myers Squibb · NCT07106762
Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features
Phase 2/Phase 3 · Amsterdam University Medical Center · Leiden University Medical Center · NCT05255653
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Phase 2 · Amsterdam Universitaire Medische Centra (UMC) - locatie Amst · Miltenyi Biomedicine GmbH · NCT04844866
Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Pa
Phase 2 · Antoni van Leeuwenhoek · The Netherlands Cancer Institute · NCT04159818
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · The Netherlands Cancer Institute · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762
The DRAGON 2 Trial
NA · Amsterdam UMC, location AMC · Maastricht University · NCT05428735
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Amsterdam UMC Locatie AMC · Boehringer Ingelheim · NCT07355296
Induction Treatment for Initially Unresectable Colorectal Liver Metastases: Combined Hepatic Arterial Infusion Pump Ther
Phase 3 · Antoni van Leeuwenhoek-Netherland Cancer Institute · The Netherlands Cancer Institute · NCT06857773
Screening for Malnutrition in Obese Patients
Phase N/A · OLVG · HAN University of Applied Sciences · NCT06626360
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · NKI The Netherlands Cancer Institute · Hoffmann-La Roche · NCT06793215
UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Phase N/A · Emma Children's Hospital, Amsterdam UMC · The Hospital for Sick Children · NCT06560606
Metabolic Heterogeneity Underlying Hypertriglyceridemia: Hepatic Triglyceride Biosynthesis in Humans With Different Insu
NA · AMC Amsterdam · Yale University · NCT05743868
Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
Phase 3 · Academisch Medisch Centrum (Amsterdam UMC) · Lakefront Biotherapeutics NV · NCT06652633
Rituximab Induced Remission in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
Phase 3 · Amsterdam UMC · Amsterdam University Medical Center (UMC), Location Academic · NCT06714838
Skeletal Muscle Mitochondria in Ageing
Phase N/A · Vrije Universiteit Amsterdam · VU University of Amsterdam · NCT06539078
Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides
Phase 4 · Faceland · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT06448676
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Onze Lieve Vrouwe Gasthuis · Amgen · NCT07037433
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Ag
Phase 1 · Amsterdam UMC, Location VUmc /ID# 267670 · AbbVie · NCT06896916
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance
Phase 1/Phase 2 · GSK Investigational Site · GlaxoSmithKline · NCT06885034
Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.
NA · Amsterdam UMC · Abraham Hulst, MD, PhD · NCT06638567
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Phase 1/Phase 2 · Antonie Van Leeuwenhoek Hospital · Deciphera Pharmaceuticals, LLC · NCT05957367
Immune-supportive Diet and Gut Permeability in Allergic Children
NA · OLVG · Onze Lieve Vrouwe Gasthuis · NCT05667610
Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervent
Phase 4 · Amsterdam UMC · J.P.S Henriques · NCT06916520
The Radium-select Study
NA · NKI-AVL · The Netherlands Cancer Institute · NCT06659926
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · Amsterdam UMC · Alimentiv Inc. · NCT07363044
Look up another city
Look up another condition